Healthcare costs within a year of respiratory syncytial virus among medicaid infants

Pediatric Pulmonology

Volumn 45, Issue 8, 2010, Pages 772-781

  Palmer, Liisa ^a   Hall, Caroline B ^b   Katkin, Julie P ^c   Shi, Nianwen ^d   Masaquel, Anthony S ^e   McLaurin, Kimmie K ^e   Mahadevia, Parthiv J ^e  

^a THOMSON REUTERS   (United Kingdom)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d THOMSON REUTERS   (United States)

^e MEDIMMUNE   (United States)

Author keywords

Costs and cost analysis; Medicaid; Respiratory syncytial virus infection; Utilization; Wheezing

Indexed keywords

ARTICLE; ASTHMA; BRONCHIOLITIS; CONTROLLED STUDY; DRUG COST; FEMALE; FOLLOW UP; GESTATIONAL AGE; HEALTH CARE COST; HOSPITAL CARE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAID; OUTPATIENT CARE; PNEUMONIA; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; SCORING SYSTEM; WHEEZING;

ASTHMA; BRONCHIOLITIS; FEMALE; GESTATIONAL AGE; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; MALE; MEDICAID; PNEUMONIA; RESPIRATORY SOUNDS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 77956101210     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.21244     Document Type: Article

References (33)

1. Shay DK, Homan RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis-associated hospitalizations among US children, 1980-1996. JAMA 1999;282:1440-1446.
2. Leader S, Kohlhase K. Recent trends in severe respiratory virus (RSV) among US infants, 1997 to 2000. J Pediatr 2003;143: S127-S132.
3. Hall CB. Respiratory syncytial virus. In: Feigin RD, Cherry JD, editors. Textbook of pediatric infectious diseases, 4th edition. Philadelphia, PA: WB Saunders Co; 1998. p. 2087.
4. Boyce TG, Mellen BG, Mitchel EF, Jr., Wright PF, Griffin MR. Rates of hospitalization for respiratory syncytial virus infection among children in Medicaid. J Pediatr 2000;137:865-870.
5. Law BJ, Langley JM, Allen U, et al. The Pediatric Investigators Collaborative Network on Infections in Canada study of predictors of hospitalization for respiratory syncytial virus infection for infants born at 33 through 35 completed weeks of gestat6ion. Pediatr Infect Dis J 2004;23:806-814.
6. Engle WA, Kominiarek MA. Late preterm infants, early term infants, and timing of elective deliveries. Clin Perinatol 2008;35: 325-341.
7. Hoo AF, Dezateux C, Henschen M, Costeloe K, Stocks J. Development of airway function in infancy after preterm delivery. J Pediatr 2002;141:652-658. (Pubitemid 35292763)
8. Wang ML, Dorer DJ, Fleming MP, Catlin EA. Clinical outcomes of near-term infants. Pediatrics 2004;114:372-376.
9. Shapiro-Mendoza CK, Tomashek KM, Kotelchuck M, Barfield W, Weiss J, Evans S. Risk factors for neonatality and morbidity among "healthy" late preterm newborns. Semin Perinatol 2006; 30:54-60.
10. Langston C, Kida K, Reed M, Thurlbeck WM. Human lung growth in late gestation and in the neonate. Am Rev Respir Dis 1984;129:607-613.
11. McLaurin KK, Hall CB, Jackson EA, Owens OV, Mahadevia PJ. Persistence of morbidity and cost differences between late-preterm and term infants during the first year of life. Pediatrics 2009;123:653-659.
12. Frogel M, Nerwen C, Cohen C, et al. Prevention of hospitalization due to respiratory syncytial virus: results from the palivizumab outcomes registry. J Perinatol 2008;28:511-517.
13. Sangare L, Curtis MP, Ahmad S. Hospitalization for respiratory syncytial virus among California infants: disparities related to race, insurance, and geography. J Pediatr 2006;149:373-377. (Pubitemid 44308426)
14. Leader S, Kohlhase K. Recent trends in severe respiratory virus (RSV) among US infants, 1997 to 2000. J Pediatr 2003;143: S127-S132.
15. Carroll KN, Gebretsadik T, Griffin MR, Wu P, Dupont WD, Mitchel EF, Enriquez R, Hartert TV. Increasing burden and risk factors for bronchiolitis-related medical visits in infants enrolled in a state health care insurance plan. Pediatrics 2008;122:58-64.
16. Klinnert MD, Price MR, Liu AH, Robinson JL. Morbidity patterns among low-income wheezing infants. Pediatrics 2003; 112:49-57.
17. Paramore LC, Ciuryla V, Ciesla G, Liu L. Economic impact of respiratory syncytial virus-related illness in the US: an analysis of national databases. Pharmacoeconomics 2004;22:275-284.
18. Hall CB, Weinberg GA, Iwane MK, et al. The burden of respiratory syncytial virus infection in young children. N Engl J Med 2009;360:588-598.
19. Howard TS, Hoffman LH, Stang PE, Simoes EA. Respiratory syncytial virus pneumonia in the hospital setting: length of stay, charges, and mortality. J Pediatr 2000;137:227-232.
20. Greenough A, Alexander J, Burgess S, Bytham J, Chetcuti PA, Hagan JK, Lenney W, Melville S, Shaw NJ, Boorman J, Coles S, Turner J, Pang F. Health care utilisation of prematurely born, preschool children related to hospitalisation for RSV infection. Arch Dis Child 2004;89:673-678.
21. Sampalis JS. Morbidity and mortality after RSV-associated hospitalizations among premature Canadian infants. J Pediatr 2003;143:S150-S156.
22. Broughton S, Roberts A, Fox G, Pollina E, Zuckerman M, Chaudhry S, Greenough A. Prospective study of healthcare utilization and respiratory morbidity due to RSV infection in prematurely born infants. Thorax 2005;60:1039-1044. (Pubitemid 41705474)
23. McConnochie KM, Roghmann KJ. RSV: management of the acute episode. Paediatr Respir Rev 1984;1:215-220.
24. Aujard Y, Faurou B. Risk factors for severe respiratory syncytial virus infection in infants.
25. Sigurs N, Bjarnason R, Sigurbergsson F, Kjellman. Respiratory syncytial virus bronchiolitis infancy is an important risk factor for asthma and allergy at age 7. Respir Med 2002; 96 (Suppl B):S9-S14.
26. Davis H, Moore RM, Gergen PJ. Cost of hospitalizations associated with sickle cell disease in the United States. Public Health Rep 1997;112:40-43. (Pubitemid 27053113)
27. Imbens GW. The role of the propensity score in estimating dose-response functions. Biometrika 2000;87:706-710.
28. Imai K, Van Dyk DA. Causal inference with general treatment regimes: generalizing the propensity score. J Am Stat Assoc 2004;99:854-866.
29. Imbens GW. Nonparametric estimation of average treatment effects under exogeneity: a review. Rev Econ Stat 2004;86:4-29.
30. Henderson J, Hilliard T, Sherriff A, et al. Hospitalization for RSV bronchiolitis before 12 months of age and subsequent asthma, atopy and wheeze: a longitudinal birth cohort study. Pediatr Allergy Immunol 2005;16:386-392.
31. Willson DF, Landrigan CP, Horn SD, Smout RJ. Complications in infants hospitalized for bronchiolitis or respiratory syncytial virus pneumonia. J Pediatr 2003;143:S142-S149. (Pubitemid 37456912)
32. Pelletier AJ, Mansbach JM, Camargo CA. Direct medical costs of bronchiolitis hospitalizations in the United States. Pediatrics 2006;118:2418-2423.
33. Makari D, Hoopes JM. Impact of RSV: implications for managed care. Manag Care 2009; 18 (1 Supp 2):2-7.